Transgenic Operative Products Overview
- Founded
- 2006
- Status
- Private
- Latest Deal Type
- Early Stage VC
- Latest Deal Amount
- $1.42M
- Investors
- 1
Transgenic Operative Products General Information
Description
Developer of a drug discovery technology intended to assist in the detection of toxic compounds in food products. The company's technology specializes in the generation of vectors and cells for research with optic imaging that aids in detecting toxic chemical compounds in the environment and food products, enabling clients to have the visualization of molecular events in real time and in all the organs.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
- Via Einstein
- Località Cascina Codazza
- 26900 Lodi
- Italy
+39 0371 000000
Transgenic Operative Products Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC | 25-Oct-2007 | $1.42M | 00.000 | Completed | Generating Revenue |
Transgenic Operative Products Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Adriana Maggi | Co-Founder, Board Member & President | ||
| Paolo Ciana Ph.D | Co-Founder, Board Member & Vice President |
Transgenic Operative Products Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Carlo Rosa | Self | Board Member | 000 0000 |
| Dario Casati | Self | Board Member | 000 0000 |
Transgenic Operative Products Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Finlombarda Gestioni | Venture Capital | Minority | 000 0000 | 000000 0 |